Art

Salt Trading Corporation Limited (STC) Reports Nearly Doubled Net Profit in Third-Quarter Results 19
Business | Market | Economy

Salt Trading Corporation Limited (STC) Reports Nearly Doubled Net Profit in Third-Quarter Results

Swabhimaan Laghubitta Bittiya Sanstha Limited (SMFBS) has recently distributed 20% bonus shares directly to the DEMAT accounts of its shareholders. The company encouraged its shareholders to dematerialize their shares in order to receive the bonus shares smoothly. During the 6th Annual General Meeting held on the 11th of Chaitra, the shareholders of SMFBS approved a

Sagarmatha Lumbini Insurance Company (SALICO) Lists 26,226,382 Shares After Merger of SIC and LGIL 21
NEPSE NEWS, Business | Market | Economy

Sagarmatha Lumbini Insurance Company (SALICO) Lists 26,226,382 Shares After Merger of SIC and LGIL

Sagarmatha Lumbini Insurance Company Limited (SALICO) has listed 26,226,382 shares on the Nepal Stock Exchange (NEPSE) following a successful merger between Lumbini General Insurance Limited (LGIL) and Sagarmatha Insurance Company Limited (SIC). The merger agreement between SIC and LGIL was signed on 30 Ashad, 2079. The swap ratio for the merger was set at 100:80,

Aatmanirbhar Laghubitta reports a decline in Q3 net profit by 27.64% 23
IPO | FPO

Aatmanirbhar Laghubitta reports a decline in Q3 net profit by 27.64%

Aatmanirbhar Laghubitta Bittiya Sanstha Limited (AATMA) has reported a 27.64% decrease in net profit for Q3 of FY 2079/2080 compared to the same quarter of the previous fiscal year, according to its unaudited financial report. The company’s net profit declined to Rs. 4.46 crores from Rs. 6.1 crores in the corresponding quarter of the previous

NIBL Ace Capital inks IPO Roadmap with Alliance Pharmaceuticals. 25
IPO | FPO

NIBL Ace Capital inks IPO Roadmap with Alliance Pharmaceuticals.

NIBL Ace Capital Limited has signed a Roadmap for an IPO agreement with Alliance Pharmaceuticals Pvt. Ltd. as part of its business consulting service. The agreement was signed in the presence of Mr. Sunil Pradhan, Managing Director of Alliance Pharmaceuticals Pvt. Ltd., and Mr. Bhuwan Raj Panta, Head of Corporate Advisory Service of NIBL Ace

Scroll to Top